A new angiogenesis prognostic index with VEGFA, PlGF, and angiopoietin 1 predicts survival in patients with advanced gastric cancer

Aktas S. H., AKBULUT H., Yazici O., Zengin N., Akgun H. N., Ustuner Z., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.47, sa.2, ss.399-406, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 47 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.3906/sag-1509-80
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.399-406
  • Anahtar Kelimeler: Docetaxel, cisplatin, 5-fluorouracil, VEGFA, angiopoietin 1, placental growth factor, angiogenesis prognostic index, gastric cancer, ENDOTHELIAL-GROWTH-FACTOR, GASTROESOPHAGEAL JUNCTION, HEPATOCELLULAR-CARCINOMA, VASCULAR MORPHOGENESIS, COLORECTAL-CANCER, CHEMOTHERAPY, EXPRESSION, CISPLATIN, THERAPY, METAANALYSIS
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background/aim: The role of angiogenic factors in gastric cancer is not clear. We aimed to assess the role of vascular endothelial growth factor A (VEGFA), angiopoietin 1 (Ang-1), and placental growth factor (PlGF) in the prognosis of patients with advanced gastric cancer.